Mariner LLC grew its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 27.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 31,309 shares of the company's stock after purchasing an additional 6,753 shares during the quarter. Mariner LLC's holdings in Doximity were worth $1,672,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in the business. Shaker Investments LLC OH acquired a new position in Doximity during the 4th quarter worth $559,000. Principal Financial Group Inc. lifted its stake in shares of Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company's stock valued at $15,695,000 after acquiring an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. acquired a new position in shares of Doximity during the fourth quarter valued at $362,000. Stratos Wealth Partners LTD. bought a new position in Doximity in the fourth quarter valued at about $203,000. Finally, Wells Fargo & Company MN increased its position in Doximity by 3.3% in the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock worth $19,698,000 after purchasing an additional 11,811 shares during the period. Institutional investors own 87.19% of the company's stock.
Insiders Place Their Bets
In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 37.40% of the company's stock.
Doximity Stock Up 0.2 %
Shares of NASDAQ:DOCS traded up $0.10 during midday trading on Monday, reaching $56.75. 1,281,408 shares of the company were exchanged, compared to its average volume of 1,990,036. The firm has a market cap of $10.59 billion, a PE ratio of 56.75, a P/E/G ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The stock has a fifty day simple moving average of $60.70 and a two-hundred day simple moving average of $56.28.
Analyst Ratings Changes
Several equities research analysts have recently commented on the stock. KeyCorp lowered their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Truist Financial lowered their target price on shares of Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a report on Thursday, April 10th. Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and upped their target price for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Bank of America raised their price target on Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Finally, Mizuho upped their price objective on Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $65.39.
View Our Latest Research Report on DOCS
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Further Reading

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.